Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Globe Newswire News Releases

Apr 18, 2024 08:00 ET
Infinite Reality Appoints Seasoned Marketing Technology Executive Karina Kogan as Chief Marketing Officer
Infinite Reality (“iR” or the “Company”), a leading global provider of cutting-edge virtual, AI-powered immersive experiences, today announced the appointment of Karina Kogan as Chief Marketing Officer. Karina Kogan is an award-winning marketing...
Apr 18, 2024 08:00 ET
Provectus Biopharmaceuticals Announces Publication of Preclinical Data of Oral Administration of Provectus Rose Bengal for Solid Tumor Cancers
Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that data from preclinical research by the University of Calgary on oral administration of Provectus’s pharmaceutical-grade rose bengal for the...
Apr 18, 2024 08:00 ET
Quest Announces Agreement with United Natural Foods, Inc to Help Accelerate the Client’s Operational and Sustainability Goals
Today, national leader in environmental waste and recycling solutions, Quest Resource Holding Corporation (NASDAQ: QRHC) ("Quest"), announced that its Quest Resource Management Group subsidiary has entered into an agreement with United Natural...
Apr 18, 2024 07:56 ET
Nitor Capital Management Issues Letter to Tejon Ranch Stockholders Announcing its Intention to Withhold Support for Four Directors at 2024 Annual Meeting
Nitor Capital Management LLC, a significant stockholder of Tejon Ranch Company (NYSE: TRC) (“Tejon Ranch” or the “Company”) which beneficially owns approximately 1.75% of Tejon Ranch’s outstanding shares, today issued the following letter to the...
Apr 18, 2024 07:52 ET
Water Ways Receives Third CAD$270K New Order for Agricultural Supplies
Water Ways Technologies Inc. (TSXV: WWT) (FRA: WWT) ("Water Ways" or the "Company"), a global provider of Israeli-based agriculture technology, providing water irrigation solutions to agricultural producers, announces that its Canadian subsidiary,...
Apr 18, 2024 07:51 ET
Central Iron Ore Limited: Drilling Update
Central Iron Ore Limited (CIO – TSX.V) (“CIO” or “the Company”) is pleased to announce this Drilling Update. South Darlot Joint VentureThe following work programme occurred: Figure 1. Drill Targets of the 2023 Q4 RC Programme MermaidNew...
Apr 18, 2024 07:45 ET
Olaplex Holdings, Inc. to Report First Quarter Fiscal 2024 Financial Results on May 2nd
Olaplex Holdings, Inc. (“OLAPLEX”), today announced that it plans to report first quarter fiscal 2024 financial results before the market opens on Thursday, May 2, 2024. The company plans to host an investor conference call and webcast to review...
Apr 18, 2024 07:34 ET
TRREB Statement on the 2024 Federal Budget
To tackle Canada’s housing affordability crisis, governments need to do two things. First, they must build more homes of all types. Second, they must lower the taxes and fees Canadians pay to find an affordable place to call home. Today’s Federal...
Apr 18, 2024 07:31 ET
CoreCard Corporation Schedules First Quarter 2024 Earnings Release and Conference Call
CoreCard Corporation (NYSE: CCRD), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, intends to hold an investor conference call on May 2, 2024, at 11:00 A.M....
Apr 18, 2024 07:30 ET
JD.com Announces Updates of Its Share Repurchase Program
JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced that, during the quarter ended March 31, 2024, the Company...
Apr 18, 2024 07:30 ET
Base Carbon Provides Corporate Update and Announces Investor Update Call
Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates, “Base Carbon”, or the “Company”), is pleased to announce that it has received...
Apr 18, 2024 07:30 ET
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today announced that it...
Apr 18, 2024 07:30 ET
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study
Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence and Replace” DNA-directed RNA interference (“ddRNAi”)...
Apr 18, 2024 07:30 ET
Bombardier to Report First Quarter Financial Results and Hold Annual General Meeting of Shareholders on April 25, 2024
Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2024 on April 25, 2024. That same day, Bombardier will hold its Annual General Meeting of Shareholders (“Meeting”) in a virtual format. Financial results for the...
Apr 18, 2024 07:30 ET
Daniel Bono Joins Two Six Technologies as SVP of Intelligence Solutions
Two Six Technologies (Two Six), a high-growth, technology-focused provider of products and expertise to U.S. national security customers, announced it has appointed Dan Bono as Senior Vice President of Intelligence Solutions. With a longstanding...
Apr 18, 2024 07:30 ET
First Generation of Advance Silicon-Based Anode Material Continues Delivering Strong Performance
HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ) (OTCQB: HPQFF) (FRA: O08), a technology company specializing in green engineering of silica and silicon-based materials is pleased to announce continued milestones achieved by its France-based...
Apr 18, 2024 07:30 ET
NevGold Announces Positive Copper Porphyry Potential at the Zeus Copper Project in the Hercules Copper Trend, Idaho
NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has identified significant copper porphyry potential after completing a geological review and 3-D model of the newly staked Zeus...
Apr 18, 2024 07:30 ET
OptimizeRx Releases 2024 Environmental, Social, and Governance (ESG) Report
OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, has published its Environmental, Social and...
Apr 18, 2024 07:30 ET
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMI
Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on providing innovative medical therapies that create positive patient stories in the hospital, community and public health settings, today announced that three new pre-clinical...